Expanding Inclusion for Long-Acting HIV Treatment Trials Workshop was held on 11/10/2022 in Washington D.C.
Materials
Session I: Opening & Introductions
Session II: Lessons Learned & Opportunities
Lessons From HCV
Greg Dore, Kirby Institute
View from the Trenches: West Virginia
Sally Hodder, Univeristy of West Virginia
Lessons from Other Fields: Psychiatry
Jonathan Liu, The George Washington University
Session III: Ensuring Access to Long-Acting ARVs -- Pre-Approval Setting
Label, Indications, and Expansion of Indications
Timothy Jancel, FDA CDER DAV
Session IV: Ensuring Access to Long-Acting ARVS -- Post-Approval Setting
ACTG 5359
Jose Castillo-Mancilla, University of Colorado Aschutz School of Medicine
Ward 86 Pilot Study
Monica Gandhi, Ward 86, UCSFn